PMID- 16880462
OWN - NLM
STAT- MEDLINE
DCOM- 20060809
LR  - 20190619
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 145
IP  - 3
DP  - 2006 Aug 1
TI  - Screening for hemochromatosis: recommendation statement.
PG  - 204-8
AB  - This statement summarizes the U.S. Preventive Services Task Force (USPSTF) 
      recommendation on screening for hemochromatosis and the supporting scientific 
      evidence. The complete information on which this statement is based, including 
      evidence tables and references, is available in the accompanying article in this 
      issue and on the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The 
      USPSTF is redesigning its recommendation statement in response to feedback from 
      primary care clinicians. The USPSTF plans to release, later in 2006, a new, 
      updated recommendation statement that is easier to read and incorporates advances 
      in USPSTF methods. The recommendation statement in this paper is an interim 
      version that combines existing language and elements with a new format. Although 
      the definitions of grades remain the same, other elements have been revised.
CN  - U.S. Preventive Services Task Force
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
SB  - IM
CIN - Ann Intern Med. 2006 Aug 1;145(3):I18. PMID: 16880456
MH  - Cost of Illness
MH  - Evidence-Based Medicine
MH  - *Genetic Testing/economics/ethics
MH  - Hemochromatosis/*diagnosis/genetics/therapy
MH  - Homozygote
MH  - Humans
MH  - Penetrance
MH  - Phlebotomy
MH  - Risk Factors
EDAT- 2006/08/02 09:00
MHDA- 2006/08/10 09:00
CRDT- 2006/08/02 09:00
PHST- 2006/08/02 09:00 [pubmed]
PHST- 2006/08/10 09:00 [medline]
PHST- 2006/08/02 09:00 [entrez]
AID - 145/3/204 [pii]
AID - 10.7326/0003-4819-145-3-200608010-00008 [doi]
PST - ppublish
SO  - Ann Intern Med. 2006 Aug 1;145(3):204-8. doi: 
      10.7326/0003-4819-145-3-200608010-00008.